These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 11291745)

  • 1. Characterization of glass solutions of poorly water-soluble drugs produced by melt extrusion with hydrophilic amorphous polymers.
    Forster A; Hempenstall J; Rades T
    J Pharm Pharmacol; 2001 Mar; 53(3):303-15. PubMed ID: 11291745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potential of small-scale fusion experiments and the Gordon-Taylor equation to predict the suitability of drug/polymer blends for melt extrusion.
    Forster A; Hempenstall J; Tucker ; Rades T
    Drug Dev Ind Pharm; 2001 Jul; 27(6):549-60. PubMed ID: 11548862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physicochemical characterization of hot melt extruded bicalutamide-polyvinylpyrrolidone solid dispersions.
    Andrews GP; AbuDiak OA; Jones DS
    J Pharm Sci; 2010 Mar; 99(3):1322-35. PubMed ID: 19798757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation of glass solutions of three poorly water soluble drugs by spray drying, melt extrusion and ball milling.
    Patterson JE; James MB; Forster AH; Lancaster RW; Butler JM; Rades T
    Int J Pharm; 2007 May; 336(1):22-34. PubMed ID: 17174493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stabilization of low glass transition temperature indomethacin formulations: impact of polymer-type and its concentration.
    Chokshi RJ; Shah NH; Sandhu HK; Malick AW; Zia H
    J Pharm Sci; 2008 Jun; 97(6):2286-98. PubMed ID: 17879977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled release of a poorly water-soluble drug from hot-melt extrudates containing acrylic polymers.
    Zhu Y; Shah NH; Malick AW; Infeld MH; McGinity JW
    Drug Dev Ind Pharm; 2006 Jun; 32(5):569-83. PubMed ID: 16720412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxypropyl cellulose stabilizes amorphous solid dispersions of the poorly water soluble drug felodipine.
    Sarode AL; Malekar SA; Cote C; Worthen DR
    Carbohydr Polym; 2014 Nov; 112():512-9. PubMed ID: 25129775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of melt extrusion in the development of a physically and chemically stable high-energy amorphous solid dispersion of a poorly water-soluble drug.
    Lakshman JP; Cao Y; Kowalski J; Serajuddin AT
    Mol Pharm; 2008; 5(6):994-1002. PubMed ID: 19434852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of physico-mechanical properties of indomethacin and polymers to assess their suitability for hot-melt extrusion processs as a means to manufacture solid dispersion/solution.
    Chokshi RJ; Sandhu HK; Iyer RM; Shah NH; Malick AW; Zia H
    J Pharm Sci; 2005 Nov; 94(11):2463-74. PubMed ID: 16200544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the Gordon-Taylor and Couchman-Karasz equations for prediction of the glass transition temperature of glass solutions of drug and polyvinylpyrrolidone prepared by melt extrusion.
    Forster A; Hempenstall J; Rades T
    Pharmazie; 2003 Nov; 58(11):838-9. PubMed ID: 14664344
    [No Abstract]   [Full Text] [Related]  

  • 11. Application and functional characterization of POVACOAT, a hydrophilic co-polymer poly(vinyl alcohol/acrylic acid/methyl methacrylate) as a hot-melt extrusion carrier.
    Xu M; Zhang C; Luo Y; Xu L; Tao X; Wang Y; He H; Tang X
    Drug Dev Ind Pharm; 2014 Jan; 40(1):126-35. PubMed ID: 23336809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physicochemical characterization and drug-release properties of celecoxib hot-melt extruded glass solutions.
    Andrews GP; Abu-Diak O; Kusmanto F; Hornsby P; Hui Z; Jones DS
    J Pharm Pharmacol; 2010 Nov; 62(11):1580-90. PubMed ID: 21072971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: stability testing of selected solid dispersions.
    Ghebremeskel AN; Vemavarapu C; Lodaya M
    Pharm Res; 2006 Aug; 23(8):1928-36. PubMed ID: 16871443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amorphous-state characterization of efavirenz--polymer hot-melt extrusion systems for dissolution enhancement.
    Sathigari SK; Radhakrishnan VK; Davis VA; Parsons DL; Babu RJ
    J Pharm Sci; 2012 Sep; 101(9):3456-64. PubMed ID: 22437488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lacidipine Amorphous Solid Dispersion Based on Hot Melt Extrusion: Good Miscibility, Enhanced Dissolution, and Favorable Stability.
    Xi L; Song H; Wang Y; Gao H; Fu Q
    AAPS PharmSciTech; 2018 Oct; 19(7):3076-3084. PubMed ID: 30094722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hot melt extrusion for amorphous solid dispersions: temperature and moisture activated drug-polymer interactions for enhanced stability.
    Sarode AL; Sandhu H; Shah N; Malick W; Zia H
    Mol Pharm; 2013 Oct; 10(10):3665-75. PubMed ID: 23961978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactive Melt Extrusion To Improve the Dissolution Performance and Physical Stability of Naproxen Amorphous Solid Dispersions.
    Liu X; Zhou L; Zhang F
    Mol Pharm; 2017 Mar; 14(3):658-673. PubMed ID: 28135108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of absorbed water on the properties of amorphous mixtures containing sucrose.
    Shamblin SL; Zografi G
    Pharm Res; 1999 Jul; 16(7):1119-24. PubMed ID: 10450941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissolution enhancement of poorly water-soluble APIs processed by hot-melt extrusion using hydrophilic polymers.
    Maniruzzaman M; Rana MM; Boateng JS; Mitchell JC; Douroumis D
    Drug Dev Ind Pharm; 2013 Feb; 39(2):218-27. PubMed ID: 22452601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amino acids as co-amorphous stabilizers for poorly water soluble drugs--Part 1: preparation, stability and dissolution enhancement.
    Löbmann K; Grohganz H; Laitinen R; Strachan C; Rades T
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):873-81. PubMed ID: 23537574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.